Nonsteroidal anti-inflammatory drug use and the risk for Alzheimer's disease: dissecting the epidemiological evidence (Q35093568)

6 August 2017

1 reference

title

Nonsteroidal anti-inflammatory drug use and the risk for Alzheimer's disease: dissecting the epidemiological evidence (English)

1 reference

6 August 2017

0 references

Lenore Launer

1

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

63

1 reference

6 August 2017

issue

8

1 reference

6 August 2017

page(s)

731-739

1 reference

Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.

6 August 2017

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Environmental risk factors for Alzheimer's disease: their relationship to age of onset and to familial or sporadic types

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

A case-control study of dementia of the Alzheimer type

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Prostaglandins stimulate calcium-dependent glutamate release in astrocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Selection of cases and controls

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Primary prevention in hypertension. Valid conclusions from observational studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Double placebo design in a prevention trial for Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

A case-control study of Alzheimer's disease in Australia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

A case-control study of Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

COX-2 as a multifunctional neuronal modulator

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Alzheimer's disease and rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Inflammation, autotoxicity and Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Association of interleukin-1 gene polymorphisms with Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Inflammatory markers in Alzheimer's disease and multi-infarct dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Nonsteroidal anti-inflammatory drug use and Alzheimer's disease: a case-control study in Rochester, Minnesota, 1980 through 1984.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Randomized pilot study of nimesulide treatment in Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Reactive oxygen species, cell signaling, and cell injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Clinical potential of cyclo-oxygenase-2 inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Effects of NSAIDs on IL-1 beta-induced IL-6 mRNA and protein synthesis in human astrocytoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Alzheimer's disease: a study of epidemiological aspects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Comparative biochemical pharmacology of the oxicams

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

Amyloid beta peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier

1 reference

https://pubmed.ncbi.nlm.nih.gov/12662122

12 December 2020

10.2165/00003495-200363080-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

6 August 2017

1020257852

0 references

1 reference